Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
DuPont de Nemours
DD
|
$286M |
| 2 |
Baker Hughes
BKR
|
$54.5M |
| 3 |
NVIDIA
NVDA
|
$40.1M |
| 4 |
Exxon Mobil
XOM
|
$39.1M |
| 5 |
Oneok
OKE
|
$35M |
Top Sells
| 1 |
RAI
Reynolds American Inc
RAI
|
$267M |
| 2 |
DD
Du Pont De Nemours E I
DD
|
$265M |
| 3 |
BHI
Baker Hughes
BHI
|
$80.5M |
| 4 |
Alibaba
BABA
|
$54.6M |
| 5 |
WFM
Whole Foods Market Inc
WFM
|
$48.9M |
Sector Composition
| 1 | Technology | 17.46% |
| 2 | Healthcare | 15.4% |
| 3 | Consumer Discretionary | 10.77% |
| 4 | Communication Services | 10.67% |
| 5 | Industrials | 10.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
McDonald's
MCD
$224B
| $586M | 0.67% | 3,737,148 -11,000 | -0.3% | -$1.72M |
|
27
Walt Disney
DIS
$213B
| $570M | 0.65% | 5,783,128 +5,800 | +0.1% | +$572K |
|
28
Oracle
ORCL
$635B
| $561M | 0.64% | 11,606,728 +136,700 | +1% | +$6.61M |
|
29
Boeing
BA
$177B
| $539M | 0.61% | 2,121,291 -4,600 | -0.2% | -$1.17M |
|
30
Mastercard
MA
$538B
| $530M | 0.6% | 3,753,420 +21,300 | +0.6% | +$3.01M |
|
31
Altria Group
MO
$113B
| $525M | 0.6% | 8,271,794 +49,600 | +0.6% | +$3.15M |
|
32
AbbVie
ABBV
$372B
| $522M | 0.59% | 5,870,329 +46,500 | +0.8% | +$4.13M |
|
33
IBM
IBM
$227B
| $513M | 0.58% | 3,535,977 +1,000 | +0% | +$145K |
|
34
Amgen
AMGN
$155B
| $506M | 0.58% | 2,712,308 +21,400 | +0.8% | +$3.99M |
|
35
Walmart
WMT
$774B
| $485M | 0.55% | 6,205,529 -3,700 | -0.1% | -$289K |
|
36
3M
MMM
$82.8B
| $475M | 0.54% | 2,260,904 +23,500 | +1% | +$4.93M |
|
37
Medtronic
MDT
$119B
| $434M | 0.49% | 5,578,963 +37,700 | +0.7% | +$2.93M |
|
|
CELG
38
DELISTED
Celgene Corp
CELG
| $420M | 0.48% | 2,878,596 +36,000 | +1% | +$5.25M |
|
|
39
Alibaba
BABA
$322B
| $396M | 0.45% | 2,293,120 -315,923 | -12% | -$54.6M |
|
|
40
NVIDIA
NVDA
$4.25T
| $392M | 0.45% | 2,193,485 +224,100 | +11% | +$40.1M |
|
41
Gilead Sciences
GILD
$140B
| $390M | 0.44% | 4,817,324 +41,800 | +0.9% | +$3.39M |
|
42
Bristol-Myers Squibb
BMY
$96B
| $388M | 0.44% | 6,091,470 -20,100 | -0.3% | -$1.28M |
|
43
Schlumberger
SLB
$55B
| $379M | 0.43% | 5,438,635 +31,800 | +0.6% | +$2.22M |
|
44
Honeywell
HON
$139B
| $378M | 0.43% | 2,669,873 +27,800 | +1% | +$3.94M |
|
45
Abbott
ABT
$231B
| $364M | 0.41% | 6,824,888 +86,500 | +1% | +$4.62M |
|
46
Broadcom
AVGO
$1.4T
| $359M | 0.41% | 1,479,613 +14,400 | +1% | +$3.49M |
|
47
Eli Lilly
LLY
$657B
| $356M | 0.41% | 4,157,443 +36,000 | +0.9% | +$3.08M |
|
48
Accenture
ACN
$162B
| $352M | 0.4% | 2,609,117 +14,000 | +0.5% | +$1.89M |
|
49
Union Pacific
UNP
$133B
| $346M | 0.39% | 2,980,472 +7,200 | +0.2% | +$835K |
|
50
Booking.com
BKNG
$181B
| $331M | 0.38% | 181,052 +1,400 | +0.8% | +$2.56M |
|